The clinical case of the child with cystic fibrosis and multiple organ failure syndrome development

Drobova, N.M.; Yanovska, K.; Pasichnyk, O.V.; Клименко, Виктория Анатольевна; Піонтковська, Оксана Володимирівна; Bevz, S. I.; Синдеева, Н Т

doi:10.15574/sp.2017.85.132

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…ŝſƉźƌƈƊſƇźƅƖƇƂƃ ƋƂƇžƊƈƆ žƟźŽƇƈƋƌƍƝƌƖƋƙ, ƄƈƅƂ ƎƍƇƄƐƟƙ ƇƂƊƈƄ ƁƇƂƀſƇź, źƅſ ƈƁƇźƄƂ ƈƊŽźƇƟƑƇƈŽƈ ƍƊźƀſƇƇƙ ƇƂƊƈƄ, ƌźƄƟ ƙƄ ŽſƆźƌƍƊƟƙ, ƉƊƈƌſƠƇƍƊƟƙ źŻƈ źƇƈ-ƆźƅƖƇź ƍƅƖƌƊźƋƈƇƈŽƊźƎƟƙ ƇƂƊƈƄ, żƟžƋƍƌƇƟ [4,13]. ŧſƁżźƀźƘƑƂ Ƈź ƌſ, Ɠƈ ŝŪū, żƟžƉƈżƟžƇƈ žƈ ŦŤů-10, Ɲ ƋźƆƈƋƌƟƃƇƈƘ ƇƈƁƈƅƈŽƟƑƇƈƘ ƎƈƊƆƈƘ, ƌźƄƂƃ ƋƌźƇ ƊƈƁżƂżźƝƌƖƋƙ ƉƟž żƉƅƂżƈƆ ƟƇƒƈŽƈ Ɓź-ƏżƈƊƘżźƇƇƙ, Ɠƈ žźƝ ƁƆƈŽƍ żƟžƇſƋƌƂ Ɛſƃ ƋƌźƇ žƈ ƌƂƉƈżƈƠ ƟƇƌſƊƎſƊſƇƐƟƠ, ƄƈƅƂ ƊƈƁżƂƌƈƄ ƊſźƅƖƇƈƠ žƂƋƎƍƇƄƐƟƠ żƟžŻƍżźƝƌƖƋƙ ƍ ƉźƐƟƝƇƌƟż ƟƁ ƌƙƀƄƈƘ ƉſƑƟƇƄƈżƈƘ ƇſžƈƋƌźƌƇƟƋƌƘ Ƈź ƌƅƟ ƐƂƊƈƁƍ Ɓ źƋƐƂ-ƌƈƆ [8].…”

Section: ŝƌƌƍɖunclassified

Hepatorenal syndrome in a child with cystic fibrosis: analysis of a clinical case

Lazarenko¹,

Kurilina²,

Hliadielova³

2022

MPU

View full text Add to dashboard Cite

Hepato-renal syndrome (HRS) is a rare complication that may accompany end-stage cystic fibrosis-associated cirrhosis in patients with cystic fibrosis. There is currently no unified protocol for the diagnosis and treatment of HRS in cystic fibrosis, particularly in pediatric patients. The main approaches to diagnosing the condition are to detect signs of acute renal failure in a patient with severe liver damage in the absence of shock and in the absence of signs of organic kidney damage or the use of nephrotoxic drugs. Treatment is based on the appointment of vasoconstrictors in combination with albumin infusion and the exclusion of factors that promote the development of HRS, but the method of final therapy remains liver transplantation. The article presents an analysis of the clinical case of HRS and its treatment in a child with cystic fibrosis. Immediate detection of liver cirrhosis in patients with cystic fibrosis, exclusion of the risk factors (massive and protracted surgical interventions, significant volume of extracted ascitic rudin, limiting the use of nephrotoxic drugs and high-dose loop diuretics) is a way to prevent the development of severe liver cirrhosis complications. Immediate recognition and proper management of HRS is a way to protect life before liver transplantation, as well as to preserve the quality of life of patients with cystic fibrosis. The research was carried out in accordance with the principles of the Helsinki Declaration. The informed consent of the patient was obtained for conducting the studies. No conflict of interests was declared by the authors. Key words: cystic fibrosis, hepatorenal syndrome, liver cirrhosis, ascites, terlipressin.

show abstract

Section: ŝƌƌƍɖunclassified